KMT2D is frequently mutated in human cancers, including SCC from various organ origins [108–110], but it is not clear whether p63-KMT2D interaction occurs in cancer cells, or whether this might be the case for other histone lysine methyltransferase members. This evidence concerns the gene TP63 and cancer.